KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Receivables (2016 - 2025)

Historic Receivables for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $11.6 billion.

  • Bristol Myers Squibb's Receivables rose 198.79% to $11.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year increase of 198.79%. This contributed to the annual value of $12.5 billion for FY2024, which is 1009.97% up from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Receivables is $11.6 billion, which was up 198.79% from $11.7 billion recorded in Q2 2025.
  • Bristol Myers Squibb's Receivables' 5-year high stood at $12.5 billion during Q1 2025, with a 5-year trough of $9.5 billion in Q2 2022.
  • Moreover, its 5-year median value for Receivables was $10.9 billion (2024), whereas its average is $11.0 billion.
  • In the last 5 years, Bristol Myers Squibb's Receivables skyrocketed by 2420.43% in 2023 and then plummeted by 1141.67% in 2024.
  • Bristol Myers Squibb's Receivables (Quarter) stood at $9.7 billion in 2021, then grew by 6.78% to $10.4 billion in 2022, then grew by 9.11% to $11.3 billion in 2023, then increased by 10.1% to $12.5 billion in 2024, then fell by 6.7% to $11.6 billion in 2025.
  • Its last three reported values are $11.6 billion in Q3 2025, $11.7 billion for Q2 2025, and $12.5 billion during Q1 2025.